Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study

por Dam, Vibeke Høyrup, Stenbæk, Dea Siggaard, Köhler-Forsberg, Kristin, Cheng Ip, Ozenne, Brice, Sahakian, Barbara Jacquelyn, Knudsen, Gitte Moos, Jørgensen, Martin Balslev, Frokjaer, Vibe Gedsoe
Publicado 2022